Form 4 for STRO SUTRO BIOPHARMA, INC.
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-13 · accession 0001209191-23-009236 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-14 | 2023-02-13 | STRO | ALBINI EDWARD C | CFO, Sec | M - OptEx | $5.81 | +45.7K | 76.4K | +149% | +$265.5K |
| D | 2023-02-14 | 2023-02-13 | STRO | ALBINI EDWARD C | CFO, Sec | M - OptEx | $0.00 | -45.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-13 | M | A | 45,698 | $5.81 | 76,406 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2023-02-13 | M | D | 45,698 | $0.00 | 0 | D | $5.81 · — to 2023-02-13 | 45,698 Common Stock | (F1) The option is fully vested and exercisable. |